Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AIM ImmunoTech Inc. Share Issue/Capital Change 2026

Jan 16, 2026

35334_nav_2026-01-16_9f45de29-e7d7-4c4b-b116-92cba50d0e74.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 0530P

AIM

16 January 2026

NOTICE

16/01/2026 - 08:00

The London Stock Exchange admits the following securities to trading on AIM:

GUNSYND PLC
50,000,000 ORDINARY SHARES OF 0.085P EACH FULLY PAID (BMD6PM5)(GB00BMD6PM55)
Pulsar Helium Inc.
100,000 COMMON SHARES OF NO PAR VALUE, FULLY PAID (DI) (BS0CZX9)(CA7459321039)
Pulsar Helium Inc.
550,000 COMMON SHARES OF NO PAR VALUE, FULLY PAID (DI) (BS0CZX9)(CA7459321039)

If you have any queries or require further information, please contact Market Operations on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

AMOGCGDBBDBDGLU